ProfileGDS4718 / 229331_at
TitleColorectal cancer: homogenized tumor tissues
OrganismHomo sapiens


no metastasis metastatic recurrence metastasis stage: 0 stage: 1 stage: 2a stage: 2b stage: 3b stage: 3c stage: 2a stage: 2b stage: 3b stage: 3c stage: 4 GSM549121 GSM549102 GSM549104 GSM549108 GSM549119 GSM549133 GSM549139 GSM549099 GSM549109 GSM549110 GSM549114 GSM549122 GSM549134 GSM549136 GSM549140 GSM549111 GSM549113 GSM549132 GSM549137 GSM549142 GSM549100 GSM549107 GSM549115 GSM549116 GSM549120 GSM549131 GSM549118 GSM549129 GSM549123 GSM549124 GSM549126 GSM549128 GSM549103 GSM549117 GSM549138 GSM549141 GSM549130 GSM549101 GSM549105 GSM549106 GSM549112 GSM549125 GSM549127 GSM549135 66% 62% 53% 48% 62% 21% 27% 51% 59% 60% 69% 44% 74% 29% 50% 78% 71% 35% 70% 50% 31% 67% 68% 63% 63% 37% 57% 20% 62% 35% 49% 49% 48% 63% 37% 56% 59% 54% 56% 57% 64% 27% 84% 25% sort by disease state sort by other Gene Expression Profile
Graph caption help
SampleTitleValueRank
GSM549121patient 080, normal, homogenized [OPG study]6.5165166
GSM549102patient 115, normal, homogenized [OPG study]6.2907562
GSM549104patient 119, normal, homogenized [OPG study]5.6530353
GSM549108patient 138, normal, homogenized [OPG study]5.468148
GSM549119patient 077, normal, homogenized [OPG study]6.2745962
GSM549133patient 032, cancer, homogenized [OPG study]4.1219821
GSM549139patient 042, cancer, homogenized [OPG study]4.3858327
GSM549099patient 107, normal, homogenized [OPG study]5.5658251
GSM549109patient 139, normal, homogenized [OPG study]6.104159
GSM549110patient 046, normal, homogenized [OPG study]6.144860
GSM549114patient 063, normal, homogenized [OPG study]6.7368269
GSM549122patient 082, normal, homogenized [OPG study]5.2057344
GSM549134patient 033, cancer, homogenized [OPG study]7.2505274
GSM549136patient 036, cancer, homogenized [OPG study]4.4570129
GSM549140patient 044, cancer, homogenized [OPG study]5.5039950
GSM549111patient 047, normal, homogenized [OPG study]7.6347578
GSM549113patient 057, normal, homogenized [OPG study]6.9760471
GSM549132patient 031, cancer, homogenized [OPG study]4.7522135
GSM549137patient 038, cancer, homogenized [OPG study]6.8822970
GSM549142patient 047, cancer, homogenized [OPG study]5.6558150
GSM549100patient 110, normal, homogenized [OPG study]4.599331
GSM549107patient 135, normal, homogenized [OPG study]6.6002567
GSM549115patient 068, normal, homogenized [OPG study]6.7604268
GSM549116patient 072, normal, homogenized [OPG study]6.3296163
GSM549120patient 078, normal, homogenized [OPG study]6.3249563
GSM549131patient 030, cancer, homogenized [OPG study]4.8007337
GSM549118patient 074, normal, homogenized [OPG study]5.9554857
GSM549129patient 027, cancer, homogenized [OPG study]4.1585620
GSM549123patient 088, normal, homogenized [OPG study]6.2953462
GSM549124patient 006, cancer, homogenized [OPG study]4.7801735
GSM549126patient 015, cancer, homogenized [OPG study]5.463249
GSM549128patient 025, cancer, homogenized [OPG study]5.428149
GSM549103patient 117, normal, homogenized [OPG study]5.4725748
GSM549117patient 073, normal, homogenized [OPG study]6.3056463
GSM549138patient 041, cancer, homogenized [OPG study]4.8223837
GSM549141patient 045, cancer, homogenized [OPG study]5.8298256
GSM549130patient 028, cancer, homogenized [OPG study]6.0568959
GSM549101patient 111, normal, homogenized [OPG study]5.7571954
GSM549105patient 128, normal, homogenized [OPG study]5.901856
GSM549106patient 134, normal, homogenized [OPG study]5.8831657
GSM549112patient 048, normal, homogenized [OPG study]6.4303364
GSM549125patient 011, cancer, homogenized [OPG study]4.4374527
GSM549127patient 024, cancer, homogenized [OPG study]8.3074684
GSM549135patient 035, cancer, homogenized [OPG study]4.2880825